| Ytd | -53.29% | |
| 1y | -37.77% |
| Open | 3.05 | Prev Close | 3.10 | Low | 3.05 | High | 3.93 | Mkt Cap | 34.16M |
| Vol | 1.62M | Avg Vol | 5.48M | EPS | -3.28 | P/E | N/A | Forward P/E | -0.87 |
| Beta | N/A | Short Ratio | 15.72 | Inst. Own | 42.68% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 3.40 | 200-d Avg | 5.76 | 1yr Est | 20.00 |
Gainers Tenon Medical (NASDAQ:TNON) shares increased by 115.8% to $0.76 during Monday's pre-mar
On June 18, 2026, CervoMed Inc., a Delaware corporation (the "Company"), entered into a Secu
CervoMed Inc. (NASDAQ:CRVO), a clinical-stage biotechnology company developing treatments for age-re
CervoMed Inc. (NASDAQ:CRVO), a clinical-stage biotechnology company developing treatments for age-r
Explanation of Responses:1. On June 11, 2026, the Issuer completed a private placement (the "Pri
HITI rose sharply in pre-market trading on strong Q2 results and continued to rise after market open
Strategic priority is to establish a partnership to advance neflamapimod into Phase 3 in dementia wi